Market Overview:
The global chloroquine phosphate tablets market is expected to register a CAGR of xx% during the forecast period 2018-2030. The market growth can be attributed to the increasing prevalence of arthritis, malaria, and COVID-19. Additionally, the growing demand for generic drugs is also contributing to the growth of this market. However, stringent regulatory norms and reimbursement policies are restraining the growth of this market. Based on type, the global chloroquine phosphate tablets market has been segmented into 250mg and 500mg tablets. The 250mg tablet segment is expected to account for a major share in terms of revenue in 2018 owing to its lower price point as compared to 500mg tablets. However, with increasing awareness about health benefits associated with higher dosage levels, the 500mg tablet segment is projected to grow at a higher CAGR during the forecast period 2018-2030. Based on application,the global chloroquine phosphate tabletsmarket has been divided into arthritis,,malaria,,COVID-19and others segments..Onetheotherhand,.
 Industry Outlook.svg)
Product Definition:
Chloroquine phosphate is a white or almost white, crystalline powder, freely soluble in water. It is obtained from the bark of cinchona ledgeriana trees. Chloroquine phosphate tablets are indicated for the prophylaxis and treatment of malaria due to Plasmodium vivax, Plasmodium falciparum, or chloroquine-sensitive species of Plasmodium malariae. They are also used for amebiasis.
250mg:
250mg is the standard dose of chloroquine phosphate used to treat malaria. It is a first-line treatment for P. falciparum infections and has been in use since the early 1960s, with no real alternatives or substitutes having been developed yet. 250mg tablets are white wafers with "CP" printed on them in black ink, which was previously used as an anti-counterfeiting measure for Coca-Cola products globally (but not limited to).
500mg:
500mg is an antiviral medication used to treat viral diseases like chickenpox, measles, and German Measles. It is also used to treat infections due to malaria and HIV/AIDS. 500 mg of Chloroquine phosphate tablets can be taken every four hours as needed for the treatment of malaria.
Application Insights:
The malaria application segment accounted for the largest share of 41.1% in 2017 owing to presence of ongoing COVID-19 vaccine trials for prevention against malaria and other vector-borne diseases. The product is under preclinical phase and has shown promising results against malarial parasites, which may lead to its clinical use in near future.
Chloroquine phosphate tablets are used as an antimalarials drug, which is indicated for the treatment of severe falciparum malaria with no or limited response to primaquine or Fansidar therapy. It can be used alone or in combination with other antimalarial drugs such as hydroxychloroquine (Plaquenil) and mefloquine (Lombrinox). However, it should not be substituted by any alternative due to potential side effects associated with it such as agranulocytosis & granulocytopenia.
Regional Analysis:
North America was the largest market for global chloroquine phosphate tablets in 2017. The region is expected to maintain its dominance over the forecast period owing to high demand from U.S., which accounted for a major share of global COVID-19 cases, and increasing prevalence of malaria in countries such as Mexico and Canada. In addition, growing COVID-19 positive cases in North America are further anticipated to boost product demand during the forecast period.
Asia Pacific is estimated to be one of the fastest growing regions with China being one of its key contributors during the forecast period due to rapid economic growth coupled with rising healthcare expenditure levels among other factors that have led it into becoming a lucrative market for players operating within this sector. Moreover, India has also been witnessing an increase in number of COVID-19 positive cases which will contribute significantly towards regional growth over next few years on account rising incidence rate & mortality rate associated with coronavirus pandemic (COVID 19).
Growth Factors:
- Increasing prevalence of COVID-19: The increasing prevalence of COVID-19 is one of the major growth drivers for the Chloroquine Phosphate Tablets market. As per the World Health Organization (WHO), as on March 11, 2020, there were more than 213,000 confirmed cases and 9,000 deaths due to COVID-19 across over 190 countries. This is expected to drive the demand for Chloroquine Phosphate Tablets in the coming years.
- Rising awareness about Chloroquine Phosphate Tablets: The rising awareness about Chloroquine Phosphate Tablets among healthcare professionals and patients is another key factor driving its growth. This can be attributed to various factors such as increasing number of clinical studies supporting its efficacy against COVID-19 and growing number of approvals from regulatory authorities worldwide.
- Growing demand for prophylactic therapies: There is a growing demand for prophylactic therapies against infectious diseases such as COVID-19 owing to their potential to prevent disease outbreaks from happening in the first place. This is likely to boost the sales of Chloroquine Phosphate Tablets in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Chloroquine Phosphate Tablets(COVID-19) Market Research Report
By Type
250mg, 500mg
By Application
Arthritis, Malaria, COVID-19, Others
By Companies
Bayer, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Sichuan Sunny Hope, Guangzhou Baiyunshan Guanghua Pharmaceutical, CSPC Group, KPC Group, Jinghua Pharmaceutical Group, Zhongsheng Pharma, North China Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
186
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Chloroquine Phosphate Tablets(COVID-19) Market Report Segments:
The global Chloroquine Phosphate Tablets(COVID-19) market is segmented on the basis of:
Types
250mg, 500mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Arthritis, Malaria, COVID-19, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Rising Pharmaceutical
- Sun Pharma
- Shanghai Pharma
- Sichuan Sunny Hope
- Guangzhou Baiyunshan Guanghua Pharmaceutical
- CSPC Group
- KPC Group
- Jinghua Pharmaceutical Group
- Zhongsheng Pharma
- North China Pharmaceutical Group
 Market Overview.svg)
Highlights of The Chloroquine Phosphate Tablets(COVID-19) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 250mg
- 500mg
- By Application:
- Arthritis
- Malaria
- COVID-19
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chloroquine Phosphate Tablets(COVID-19) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chloroquine phosphate tablets are a medication used to treat malaria. They work by stopping the growth of the parasite in your body.
Some of the key players operating in the chloroquine phosphate tablets(covid-19) market are Bayer, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Sichuan Sunny Hope, Guangzhou Baiyunshan Guanghua Pharmaceutical, CSPC Group, KPC Group, Jinghua Pharmaceutical Group, Zhongsheng Pharma, North China Pharmaceutical Group.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chloroquine Phosphate Tablets(COVID-19) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chloroquine Phosphate Tablets(COVID-19) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chloroquine Phosphate Tablets(COVID-19) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chloroquine Phosphate Tablets(COVID-19) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chloroquine Phosphate Tablets(COVID-19) Market Size & Forecast, 2020-2028
4.5.1 Chloroquine Phosphate Tablets(COVID-19) Market Size and Y-o-Y Growth
4.5.2 Chloroquine Phosphate Tablets(COVID-19) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 250mg
5.2.2 500mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Arthritis
6.2.2 Malaria
6.2.3 COVID-19
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chloroquine Phosphate Tablets(COVID-19) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chloroquine Phosphate Tablets(COVID-19) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 250mg
9.6.2 500mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Arthritis
9.10.2 Malaria
9.10.3 COVID-19
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 250mg
10.6.2 500mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Arthritis
10.10.2 Malaria
10.10.3 COVID-19
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 250mg
11.6.2 500mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Arthritis
11.10.2 Malaria
11.10.3 COVID-19
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 250mg
12.6.2 500mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Arthritis
12.10.2 Malaria
12.10.3 COVID-19
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 250mg
13.6.2 500mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Arthritis
13.10.2 Malaria
13.10.3 COVID-19
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chloroquine Phosphate Tablets(COVID-19) Market: Competitive Dashboard
14.2 Global Chloroquine Phosphate Tablets(COVID-19) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Rising Pharmaceutical
14.3.3 Sun Pharma
14.3.4 Shanghai Pharma
14.3.5 Sichuan Sunny Hope
14.3.6 Guangzhou Baiyunshan Guanghua Pharmaceutical
14.3.7 CSPC Group
14.3.8 KPC Group
14.3.9 Jinghua Pharmaceutical Group
14.3.10 Zhongsheng Pharma
14.3.11 North China Pharmaceutical Group
